Author
Aaron D. Schmookler, MD
Department of Pathology
University of Kentucky College of Medicine
Lexington, Kentucky
Adapted from Ipe T. Atypical hemolytic uremic syndrome. ASCP Case Rep Transfus Med. 2015;15(7).
Primary Audience: Pathologists and Clinical Scientists
Secondary Audience: Residents, Laboratory Technologist/Scientist (Includes all sub-specialty areas), Students, Pathologist Assistants, Laboratory Directors and Educators
Upon completion of this activity, you will be able to:
· differentiate atypical hemolytic uremic syndrome (aHUS) from other thrombotic microangiopathies, such as thrombotic thrombocytopenic purpura and Shiga toxin–producing enterohemorrhagic Escherichia coli hemolytic uremic syndrome;
· analyze clinical and laboratory presentations associated with aHUS;
· describe the pathogenesis of aHUS;
· choose appropriate laboratory tests for the diagnosis of aHUS; and
· appraise the utility of plasma exchange and monoclonal antibody therapy for aHUS.